Jianwei Xiao Selected Research

ginsenoside Rk2

1/2022

Ginsenoside Rk2 Protects against Ulcerative Colitis via Inactivating ERK/MEK Pathway by SIRT1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jianwei Xiao Research Topics

Disease

4	Rheumatoid Arthritis 01/2022 - 03/2021
2	Osteoarthritis 03/2022 - 01/2021
1	Arthritis (Polyarthritis) 01/2022
1	Ulcerative Colitis 01/2022
1	Lupus Nephritis 01/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021
1	Carcinoma (Carcinomatosis) 02/2012
1	Neoplasms (Cancer) 02/2012
1	Autoimmune Diseases (Autoimmune Disease) 02/2012
1	Stomach Neoplasms (Stomach Cancer) 02/2012

Drug/Important Bio-Agent (IBA)

2	Circular RNAIBA 03/2022 - 01/2021
2	CytokinesIBA 01/2022 - 03/2021
1	ermiaoIBA 01/2022
1	Sirtuin 1IBA 01/2022
1	CurcuminIBA 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	Interleukin-17 (Interleukin 17)IBA 01/2022
1	Oxidoreductases (Dehydrogenase)IBA 01/2022
1	NeuropeptidesIBA 01/2022
1	6-methyladenineIBA 01/2022
1	ginsenoside Rk2IBA 01/2022
1	AntioxidantsIBA 01/2022
1	Long Noncoding RNAIBA 03/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Interferon Type IIBA 01/2021
1	Interleukin-12 (IL 12)IBA 02/2012
1	4-1BB Ligand (4 1BB Ligand)IBA 02/2012
1	RNA (Ribonucleic Acid)IBA 02/2012
1	VaccinesIBA 02/2012

Therapy/Procedure

1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022